BCG vaccination in infancy does not protect against COVID-19. Evidence from a natural experiment in Sweden
Cl\'ement de Chaisemartin, Luc de Chaisemartin

TL;DR
This study uses a natural experiment in Sweden to evaluate whether BCG vaccination at birth provides protection against COVID-19, finding no significant protective effect based on large-scale cohort data and regression analysis.
Contribution
It provides the first large-scale, natural experiment-based evidence that BCG vaccination at birth does not significantly reduce COVID-19 cases or hospitalizations.
Findings
No more than 20% reduction in COVID-19 cases
No more than 24% reduction in hospitalizations
Large population data enhances estimate precision
Abstract
The Bacille Calmette-Gu\'erin (BCG) tuberculosis vaccine has immunity benefits against respiratory infections. Accordingly, it has been hypothesized that it may have a protective effect against COVID-19. Recent research found that countries with universal Bacillus Calmette-Gu\'erin (BCG) childhood vaccination policies tend to be less affected by the COVID-19 pandemic. However, such ecological studies are biased by numerous confounders. Instead, this paper takes advantage of a rare nationwide natural experiment that took place in Sweden in 1975, where discontinuation of newborns BCG vaccination led to a dramatic fall of the BCG coverage rate from 92% to 2% , thus allowing us to estimate the BCG's effect without all the biases associated with cross-country comparisons. Numbers of COVID-19 cases and hospitalizations were recorded for birth cohorts born just before and just after that…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsImmune responses and vaccinations · COVID-19 Impact on Reproduction · Neonatal Respiratory Health Research
